Skip to main content
. 2012 Aug;56(8):4463–4465. doi: 10.1128/AAC.06354-11

Table 2.

Antibacterial and macromolecular inhibitory concentrations of LFF571

Test agent IC50 (μg/ml ± SD)a
Antibacterial concn (μg/ml)b
[3H]leucine [3H]NAGc
LFF571 0.06 ± 0.004 (n = 5) >1 (n = 5) 0.03
Tetracycline 10.2 ± 4.3 (n = 5) >32 (n = 5) 8
Vancomycin >32 (n = 5) 2.6 ± 1.9 (n = 6) 4
a

Values represent means ± standard deviation (SD).

b

Antibacterial concentrations were determined using the same medium and inoculum with which the macromolecular synthesis experiments were performed. Strain NB95026 was used for all assays.

c

NAG, N-aeetylglucosamine.

HHS Vulnerability Disclosure